Acadian Asset Management LLC Veru Inc. Transaction History

Acadian Asset Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 09, 2020	SELL	$2.58 - $3.36 $171,441 - $223,272	-66,450 Closed	0 $0
Q2 2020 Aug 12, 2020	SELL	$3.01 - $4.02 $50,953 - $68,050	-16,928 Reduced 20.3%	66,450 $222,000
Q1 2020 May 11, 2020	BUY	$2.58 - $4.58 $168,621 - $299,335	65,357 Added 362.67%	83,378 $272,000
Q4 2019 Feb 06, 2020	BUY	$1.86 - $3.35 $16,909 - $30,454	9,091 Added 101.8%	18,021 $60,000
Q3 2019 Nov 07, 2019	BUY	$1.81 - $2.36 $16,163 - $21,074	8,930 New	8,930 $19,000

115

58M

539K

367K

Ticker VERU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,146,704
Market Cap $61.7M
Description
Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Acadian Asset Management LLC with notifications on news.